TY - JOUR AU - P. Bartholo, Thiago AU - C. P么rto, Luis AU - H. Costa, Claudia AU - Jos茅 Lopes, Agnaldo AU - P. Gra莽a, Nadja AU - O. Chibante, Fernanda AU - J. C. Bessa, Elizabeth AU - S. Nunes, Alessandra AU - L. Rufino, Rog茅rio PY - 2022/01/04 Y2 - 2024/10/12 TI - Smoking and COVID 19: Analysing this controversy in a Brazilian COVID-19 Reference Centre JF - 香港六合彩开奖结果 JA - BJHBS VL - 20 IS - 2 SE - Original Articles DO - 10.12957/bjhbs.2021.63961 UR - /bjhbs/article/view/32 SP - 105-108 AB - <p>Introduction: Due to the COVID-19 pandemic, it is ex-tremely important to determine the risk factors that define patients who are more susceptible to the severe form of the disease; however, the observation of supposedly pro-tective factors is also of great relevance. Smoking has been the subject of controversy as to whether it is a protective factor or a risk factor for COVID-19. Objective: To assess how smokers behave within the context of the COVID-19 pandemic. Patients and methods: The participants in this study were a spontaneously recruited sample from the Rio de Janeiro State University COVID-19 Reference Centre, between March and May 2020. All patients underwent clinical, laboratory, and nasal swabs for the Sars-Cov-2 PCR investigation. Whenever it was the necessary case, patients were referred to hospitalization. Results: A total of 4,636 patients with suggestive symptoms of COVID were evalu-ated. There was 230 (4.9%) smokers in this group; there is a 10.3% smoking prevalence in the state of Rio de Janeiro as described in 2018. A number of 2,246 patients (48.6% of the total sample) were diagnosed with COVID-19, only 82 of these (3.7% of the total positive COVID) were smokers. Only 1 (0.01%) of the smokers with COVID-19 needed hospitalization. As far as the assessed symptoms, smokers showed fewer symptoms during the disease. Conclusion: The study suggests that smokers have fewer symptoms (mild or asymptomatic symptoms) and that there is a need to expand specific testing for that group.</p> ER -